Five teams selected to investigate new frontiers in communicable diseases

QILAI SHEN / PANOS PICTURES Technicians work at a laboratory at a Cyagen Biosciences Inc. facility.

IDRC, the Azrieli Foundation, the Canadian Institutes of Health Research and the Israel Science Foundation are pleased to announce the recipients of the second research competition under phase II of the prestigious Joint Canada-Israel Health Research Program. These world-class investigators will advance global scientific discovery and collaboration to address intractable communicable diseases.

The five selected teams will receive funding totaling CAD7.5 million over the next four years. The funded researchers are based in leading institutions in Canada, Israel, Ghana, Brazil and Argentina.

Communicable diseases present a major threat to health and societies. Recent changes in the patterns of incidence of communicable diseases, including new threats such as emerging infectious diseases, biosecurity issues and climate change, have created a situation that cannot be ignored. Research on unknown biological mechanisms and their implications for global health is urgently needed and well aligned with the United Nations’ Sustainable Development Goal 3, which commits global action to end the epidemics of major communicable diseases such as AIDS, malaria, tuberculosis and other neglected diseases.

Using cutting-edge technologies, the research teams will advance understanding of the complex factors that contribute to several communicable diseases and uncover potential new targets for prevention, diagnosis and treatment that can promote equitable health outcomes for all.

Researchers from Ghana, Argentina, Brazil, Canada and Israel will work collaboratively to strengthen scientific capacity and promote collaboration, equitable partnerships and scientific excellence in all its diversity.

Selected research projects

The second call for proposals under the research program was launched in September 2022. The call was directed toward applicants conducting research in the broad area of communicable diseases while strengthening capacity in Canada, Israel and low- and middle-income countries.

The proposals were evaluated in June 2023 by an international committee of 19 experts from 10 countries, chaired by Dr. Michel Nussenzweig of Rockefeller University, USA. Five projects led by world-class teams based in Canada, Israel, Ghana, Argentina and Brazil were selected from among 36 proposals.

The selected projects are:

These projects will add to the 36 joint projects previously selected through the first and second phases of the program.


Originally published by IDRC. View the original article here.